CSL

Tavneos

Pharma

EU regulators offer post-mortem of Tavneos withdrawal decision

EU regulators have outlined concerns that led to last week's formal revocation of the marketing authorization for the rare-disease med Tavneos.

Fraiser Kansteiner Aug 14, 2026 11:04am

Sanofi

Sanofi offers commitments to end EU flu shot antitrust probe

Jul 8, 2026 4:26pm

Sanofi

EC begins antitrust probe into Sanofi's flu shot campaign

Jun 26, 2026 11:20am

CSL Behring Kankakee Illinois site

CSL cuts FY26 revenue projection by $600M, writes off $5B

May 11, 2026 11:30am

topic report

drug prices biologics drug costs IRA money cash payment co-pay

Top 20 pharma companies by 2025 revenue

Apr 20, 2026 3:00am

CSL CSL Behring Kankakee Illinois

CSL firms up details on $1.5B US plasma-based medicines plant

Mar 10, 2026 10:30am